Chateal EQ
Oral Contraception
ApprovedActive
Key Facts
About Afaxys
Afaxys is a specialized generic drug company with a clear social mission to improve access to affordable reproductive healthcare. It operates as a commercial-stage enterprise, marketing a portfolio of AB-rated generic oral contraceptives, the over-the-counter emergency contraceptive EContra One-Step, and the contraceptive patch Twirla (as a promotional partner). The company's core strategy involves partnering with federally qualified health centers, clinics, and public health providers to ensure a stable supply of essential medications for underserved populations, positioning itself as a key supplier in this niche segment of the generic drug market.
View full company profileTherapeutic Areas
Other Oral Contraception Drugs
| Drug | Company | Phase |
|---|---|---|
| Aubra EQ | Afaxys | Approved |
| Cyred EQ | Afaxys | Approved |
| Jasmiel | Afaxys | Approved |
| Tarina 24 Fe | Afaxys | Approved |
| Tarina Fe 1/20 EQ | Afaxys | Approved |
| Tri-VyLibra | Afaxys | Approved |
| Tri-VyLibra Lo | Afaxys | Approved |
| VyLibra | Afaxys | Approved |
| Nextstellis® | Mayne Pharma Group | Marketed |